Sutro Biopharma Share Holder Equity 2017-2022 | STRO

Sutro Biopharma share holder equity from 2017 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
Sutro Biopharma Annual Share Holder Equity
(Millions of US $)
2021 $253
2020 $332
2019 $98
2018 $132
2017 $-6
2016 $12
Sutro Biopharma Quarterly Share Holder Equity
(Millions of US $)
2022-03-31 $220
2021-12-31 $253
2021-09-30 $284
2021-06-30 $308
2021-03-31 $307
2020-12-31 $332
2020-09-30 $244
2020-06-30 $207
2020-03-31 $82
2019-12-31 $98
2019-09-30 $110
2019-06-30 $120
2019-03-31 $131
2018-12-31 $132
2018-09-30 $46
2018-06-30 $0
2018-03-31 $0
2017-12-31
2017-09-30 $0
2016-12-31 $12
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.246B $0.062B
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
Bio-Rad Laboratories (BIO.B) United States $14.907B 32.33
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00